The DNA Methylation Landscape of PD-1 (PDCD1) and Adjacent LncRNA AC131097.3 in Head and Neck Squamous Cell Carcinoma

References

• Siegel RL , MillerKD , JemalA. Cancer statistics, 2020. CA Cancer J. Clin.70(1), 7–30 (2020).
   PubMed Web of Science ®Google Scholar
• Gillison ML , KochWM , CaponeRBet al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl Cancer Inst.92(9), 709–720 (2000).
   PubMed Web of Science ®Google Scholar
• Ang KK , HarrisJ , WheelerRet al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med.363(1), 24–35 (2010).
   PubMed Web of Science ®Google Scholar
• Leemans CR , BraakhuisBJM , BrakenhoffRH. The molecular biology of head and neck cancer. Nat. Rev. Cancer11(1), 9–22 (2011).
   PubMed Web of Science ®Google Scholar
• zur Hausen H . The search for infectious causes of human cancers: where and why. Virology392(1), 1–10 (2009).
   PubMed Web of Science ®Google Scholar
• zur Hausen H . Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer2(5), 342–350 (2002).
   PubMed Web of Science ®Google Scholar
• Slebos RJC , YiY , ElyKet al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin. Cancer Res.12(3 Pt 1), 701–709 (2006).
   PubMed Web of Science ®Google Scholar
• Schoppy DW , SunwooJB. Immunotherapy for head and neck squamous cell carcinoma. Hematol/Oncol Clin. North Am.29(6), 1033–1043 (2015).
   PubMed Web of Science ®Google Scholar
• Ang KK , ChenA , CurranWJet al. Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN). Cancer118(23), 5783–5792 (2012).
   PubMed Web of Science ®Google Scholar
• Kleffel S , PoschC , BarthelSRet al. Melanoma cell-intrinsic PD-1 receptor functions promote tumor growth. Cell162(6), 1242–1256 (2015).
   PubMed Web of Science ®Google Scholar
• Okazaki T , HonjoT. PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol.19(7), 813–824 (2007).
   PubMed Web of Science ®Google Scholar
• Zech HB , LabanS , SchafhausenP , BussmannL , BetzC , BuschC-J. Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: highlights des ASCO-Meetings 2019. HNO67(12), 898–904 (2019).
   PubMedGoogle Scholar
• Larkins E , BlumenthalGM , YuanWet al. FDA approval summary: pembrolizumab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma with disease progression on or after platinum-containing chemotherapy. Oncologist22(7), 873–878 (2017).
   PubMed Web of Science ®Google Scholar
• Sen DR , KaminskiJ , BarnitzRAet al. The epigenetic landscape of T cell exhaustion. Science354(6316), 1165–1169 (2016).
   PubMed Web of Science ®Google Scholar
• Pauken KE , SammonsMA , OdorizziPMet al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Science354(6316), 1160–1165 (2016).
   PubMed Web of Science ®Google Scholar
• Robertson KD . DNA methylation and human disease. Nat. Rev. Genet.6(8), 597–610 (2005).
   PubMed Web of Science ®Google Scholar
• Johnson AA , AkmanK , CalimportSRG , WuttkeD , StolzingA , de MagalhãesJP. The role of DNA methylation in aging, rejuvenation, and age-related disease. Rejuvenation Res.15(5), 483–494 (2012).
   PubMed Web of Science ®Google Scholar
• Taby R , IssaJ-PJ. Cancer epigenetics. CA Cancer J. Clin.60(6), 376–392 (2010).
   PubMed Web of Science ®Google Scholar
• Jones PA . Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat. Rev. Genet.13(7), 484–492 (2012).
   PubMed Web of Science ®Google Scholar
• Schmidl C , DelacherM , HuehnJ , FeuererM. Epigenetic mechanisms regulating T-cell responses. J. Allergy Clin. Immunol.142(3), 728–743 (2018).
   PubMed Web of Science ®Google Scholar
• Ghoneim HE , ZamoraAE , ThomasPG , YoungbloodBA. Cell-intrinsic barriers of T cell-based immunotherapy. Trends Mol. Med.22(12), 1000–1011 (2016).
   PubMed Web of Science ®Google Scholar
• Yang X , HanH , de CarvalhoDD , LayFD , JonesPA , LiangG. Gene body methylation can alter gene expression and is a therapeutic target in cancer. Cancer Cell26(4), 577–590 (2014).
   PubMed Web of Science ®Google Scholar
• Ehrlich M , LaceyM. DNA methylation and differentiation: silencing, upregulation and modulation of gene expression. Epigenomics5(5), 553–568 (2013).
   PubMed Web of Science ®Google Scholar
• Esteller M , Garcia-FoncillasJ , AndionEet al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N. Engl. J. Med.343(19), 1350–1354 (2000).
   PubMed Web of Science ®Google Scholar
• Church TR , WandellM , Lofton-DayCet al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer. Gut63(2), 317–325 (2014).
   PubMed Web of Science ®Google Scholar
• Partin AW , van NesteL , KleinEAet al. Clinical validation of an epigenetic assay to predict negative histopathological results in repeat prostate biopsies. J. Urol.192(4), 1081–1087 (2014).
   PubMed Web of Science ®Google Scholar
• van Kessel KEM , BeukersW , LurkinIet al. Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy. J. Urol.197(3 Pt 1), 590–595 (2017).
   PubMed Web of Science ®Google Scholar
• Imperiale TF , RansohoffDF , ItzkowitzSH. Multitarget stool DNA testing for colorectal-cancer screening. N. Engl. J. Med.371(2), 187–188 (2014).
   PubMedGoogle Scholar
• Kataoka K , ShiraishiY , TakedaYet al. Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers. Nature534(7607), 402–406 (2016).
   PubMed Web of Science ®Google Scholar
• Ricci C , MorandiL , RighiAet al. PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters. Mod. Pathol.32(9), 1359–1372 (2019).
   PubMed Web of Science ®Google Scholar
• Goltz D , GevenslebenH , DietrichJet al. PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients. Oncotarget8(25), 41011–41020 (2017).
   PubMedGoogle Scholar
• Goltz D , GevenslebenH , DietrichJet al. Promoter methylation of the immune checkpoint receptor PD-1 (PDCD1) is an independent prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy. Oncoimmunology5(10), e1221555 (2016).
   PubMed Web of Science ®Google Scholar
• Röver LK , GevenslebenH , DietrichJet al. PD-1 (PDCD1) promoter methylation is a prognostic factor in patients with diffuse lower-grade gliomas harboring isocitrate dehydrogenase (IDH) mutations. EBioMedicine28, 97–104 (2018).
   PubMed Web of Science ®Google Scholar
• Sannigrahi MK , SharmaR , SinghV , PandaNK , RattanV , KhullarM. Role of host miRNA Hsa-miR-139-3p in HPV-16-induced carcinomas. Clin. Cancer Res.23(14), 3884–3895 (2017).
   PubMed Web of Science ®Google Scholar
• Li H , ShengY , ZhangY , GaoN , DengX , ShengX. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene. Gynecol. Oncol.145(3), 569–576 (2017).
   PubMed Web of Science ®Google Scholar
• Huarte M , RinnJL. Large non-coding RNAs: missing links in cancer?Hum. Mol. Genet.19(R2), R152–R161 (2010).
   PubMed Web of Science ®Google Scholar
• Yu F , ChenB , DongP , ZhengJ. HOTAIR epigenetically modulates PTEN expression via MicroRNA-29b: a novel mechanism in regulation of liver fibrosis. Mol. Ther.25(1), 205–217 (2017).
   PubMed Web of Science ®Google Scholar
• Lewis BP , BurgeCB , BartelDP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell120(1), 15–20 (2005).
   PubMed Web of Science ®Google Scholar
• Shao Y , ZhangD , LiXet al. MicroRNA-203 increases cell radiosensitivity via directly targeting Bmi-1 in hepatocellular carcinoma. Mol. Pharm.15(8), 3205–3215 (2018).
   PubMedGoogle Scholar
• Marchese FP , RaimondiI , HuarteM. The multidimensional mechanisms of long noncoding RNA function. Genome Biol.18(1), 206 (2017).
   PubMed Web of Science ®Google Scholar
• Yang X , WangCC , LeeWYW , TrovikJ , ChungTKH , KwongJ. Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U. Cancer Lett.413, 23–34 (2018).
   PubMed Web of Science ®Google Scholar
• Smit EF , BaasP. Lung cancer in 2015: bypassing checkpoints, overcoming resistance, and honing in on new targets. Nature reviews. Clin. Oncol.13(2), 75–76 (2016).
   Web of Science ®Google Scholar
• Li H , YuB , LiJet al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget5(8), 2318–2329 (2014).
   PubMedGoogle Scholar
• Rui X , XuY , HuangY , JiL , JiangX. lncRNA DLG1-AS1 promotes cell proliferation by competitively binding with miR-107 and up-regulating ZHX1 expression in cervical cancer. Cell. Physiol. Biochem.49(5), 1792–1803 (2018).
   PubMedGoogle Scholar
• Wu F , ZhaoZ , ChaiRet al. Expression profile analysis of antisense long noncoding RNA identifies WDFY3-AS2 as a prognostic biomarker in diffuse glioma. Cancer Cell Int.18, 107 (2018).
   PubMed Web of Science ®Google Scholar
• Wang Q , ZhangJ , LiuYet al. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma. Cancer Lett.373(2), 251–259 (2016).
   PubMed Web of Science ®Google Scholar
• Mineo M , RicklefsF , RoojAKet al. The long non-coding RNA HIF1A-AS2 facilitates the maintenance of mesenchymal glioblastoma stem-like cells in hypoxic niches. Cell Rep.15(11), 2500–2509 (2016).
   PubMed Web of Science ®Google Scholar
• Sailer V , SailerU , BawdenEGet al. DNA methylation of indoleamine 2,3-dioxygenase 1 (IDO1) in head and neck squamous cell carcinomas correlates with IDO1 expression, HPV status, patients’ survival, immune cell infiltrates, mutational load, and interferon γ signature. EBioMedicine48, 341–352 (2019).
   PubMed Web of Science ®Google Scholar
• Holderried TAW , de VosL , BawdenEGet al. Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma. Clin. Epi.11(1), 161 (2019).
   Google Scholar
• Klümper N , RalserDJ , BawdenEGet al. LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma. J. Immunother. Cancer8(1), e000552 (2020).
   PubMed Web of Science ®Google Scholar
• Fröhlich A , LoickS , BawdenEGet al. Comprehensive analysis of tumor necrosis factor receptor TNFRSF9 (4-1BB) DNA methylation with regard to molecular and clinicopathological features, immune infiltrates, and response prediction to immunotherapy in melanoma. EBioMedicine52, 102647 (2020).
   PubMed Web of Science ®Google Scholar
• Micevic G , ThakralD , McGearyM , BosenbergMW. PD-L1 methylation regulates PD-L1 expression and is associated with melanoma survival. Pigment Cell Melanoma Res.32(3), 435–440 (2019).
   PubMed Web of Science ®Google Scholar
• Franzen A , VogtTJ , MüllerTet al. PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas. Oncotarget9(1), 641–650 (2018).
   PubMedGoogle Scholar
• de Vos L , GrünwaldI , BawdenEGet al. The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas. Epigenetics15(11), 1195–1212 (2020).
   PubMed Web of Science ®Google Scholar
• The Cancer Genome Atlas Network . Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature517(7536), 576–582 (2015).
   PubMed Web of Science ®Google Scholar
• Chakravarthy A , HendersonS , ThirdboroughSMet al. Human papillomavirus drives tumor development throughout the head and neck: improved prognosis is associated with an immune response largely restricted to the oropharynx. J. Clin. Oncol.34(34), 4132–4141 (2016).
   PubMed Web of Science ®Google Scholar
• Kandoth C , McLellanMD , VandinFet al. Mutational landscape and significance across 12 major cancer types. Nature502(7471), 333–339 (2013).
   PubMed Web of Science ®Google Scholar
• Edgar R , DomrachevM , LashAE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. 30(1), 207–210 (2002).
   Google Scholar
• Thorsson V , GibbsDL , BrownSDet al. The immune landscape of cancer. Immunity51(2), 411–412 (2019).
   PubMed Web of Science ®Google Scholar
• Saltz J , GuptaR , LeHet al. Spatial organization and molecular correlation of tumor-infiltrating lymphocytes using deep learning on pathology images. Cell Reports23(1), 181–193.e7 (2018).
   PubMed Web of Science ®Google Scholar
• Partlová S , BoučekJ , KloudováKet al. Distinct patterns of intratumoral immune cell infiltrates in patients with HPV-associated compared to nonvirally induced head and neck squamous cell carcinoma. Oncoimmunology4(1), e965570 (2015).
   PubMed Web of Science ®Google Scholar
• Gavrielatou N , DoumasS , EconomopoulouP , FoukasPG , PsyrriA. Biomarkers for immunotherapy response in head and neck cancer. Cancer Treatment Rev.84, 101977 (2020).
   PubMed Web of Science ®Google Scholar
• Bauml JM , AggarwalC , CohenRB. Immunotherapy for head and neck cancer: where are we now and where are we going?Ann. Transl. Med.7(Suppl. 3), S75 (2019).
   PubMedGoogle Scholar
• Denaro N , MerlanoMC. Immunotherapy in head and neck squamous cell cancer. Clin. Exp. Otorhinolaryngol.11(4), 217–223 (2018).
   PubMed Web of Science ®Google Scholar
• Saleh K , EidR , HaddadFG , Khalife-SalehN , KourieHR. New developments in the management of head and neck cancer – impact of pembrolizumab. Ther. Clin. Risk Manag.14, 295–303 (2018).
   PubMed Web of Science ®Google Scholar
• Lechner M , FentonTR. The genomics, epigenomics, and transcriptomics of HPV-associated oropharyngeal cancer-understanding the basis of a rapidly evolving disease. Adv. Genet.93, 1–56 (2016).
   PubMed Web of Science ®Google Scholar
• Lyford-Pike S , PengS , YoungGDet al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPV-associated head and neck squamous cell carcinoma. Cancer Res.73(6), 1733–1741 (2013).
   PubMed Web of Science ®Google Scholar
• Youngblood B , OestreichKJ , HaS-Jet al. Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells. Immunity35(3), 400–412 (2011).
   PubMed Web of Science ®Google Scholar
• McPherson RC , KonkelJE , PrendergastCTet al. Epigenetic modification of the PD-1 (Pdcd1) promoter in effector CD4(+) T cells tolerized by peptide immunotherapy. eLife3, e03416 (2014).
   PubMed Web of Science ®Google Scholar
• Ikawa T , MasudaK , EndoTAet al. Conversion of T cells to B cells by inactivation of polycomb-mediated epigenetic suppression of the B-lineage program. Genes Deve.30(22), 2475–2485 (2016).
   PubMed Web of Science ®Google Scholar
• Fröhlich A , SirokayJ , FietzSet al. Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanoma. EBioMedicine59, 102962 (2020).
   PubMed Web of Science ®Google Scholar
• Gameiro SF , GhasemiF , BarrettJWet al. Treatment-naïve HPV+ head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy. Oncoimmunology7(10), e1498439 (2018).
   PubMed Web of Science ®Google Scholar
• Cabili MN , TrapnellC , GoffLet al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev.25(18), 1915–1927 (2011).
   PubMed Web of Science ®Google Scholar
• Guglas K , BogaczyńskaM , KolendaTet al. lncRNA in HNSCC: challenges and potential. Contemp. Oncol. (Pozn).21(4), 259–266 (2017).
   PubMed Web of Science ®Google Scholar
• Shi T , GaoG , CaoY. Long noncoding RNAs as novel biomarkers have a promising future in cancer diagnostics. Dis. Markers2016, 9085195 (2016).
   PubMed Web of Science ®Google Scholar
• Gibb EA , EnfieldKSS , StewartGLet al. Long noncoding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral Oncology47(11), 1055–1061 (2011).
   PubMed Web of Science ®Google Scholar
• Wu J , XieH. Expression of long noncoding RNA-HOX transcript antisense intergenic RNA in oral squamous cell carcinoma and effect on cell growth. Tumour Biol.36(11), 8573–8578 (2015).
   PubMedGoogle Scholar
• Wu Y , ZhangL , ZhangLet al. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Int. J. Oncol.46(6), 2586–2594 (2015).
   PubMed Web of Science ®Google Scholar
• Dietrich D , LescheR , TetznerRet al. Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. J. Histochem. Cytochem.57(5), 477–489 (2009).
   PubMed Web of Science ®Google Scholar
• Uhl B , GevenslebenH , TolkachYet al. PITX2 DNA methylation as biomarker for individualized risk assessment of prostate cancer in core biopsies. J. Mol. Diagn.19(1), 107–114 (2017).
   PubMed Web of Science ®Google Scholar
• Goltz D , GevenslebenH , VogtTJet al. CTLA4 methylation predicts response to anti-PD-1 and anti-CTLA-4 immunotherapy in melanoma patients. JCI Insight3(13), e96793 (2018).
   PubMed Web of Science ®Google Scholar
• Li J , HanL , RoebuckPet al. TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. Cancer Res. 75(18), 3728–3737 (2016).
   Web of Science ®Google Scholar